InsidersTradesSigma
Follow the Genovis AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Healthcare & Pharma sector, Genovis AB has logged 8 insider filings. Market capitalisation: €1.5bn. The latest transaction was reported on 15 May 2026 (Purchase). Among the most active insiders: Steven Jordan. All data is openly available.
8
Insider Decl.
n/a
Thresholds
€155,849
6 ops.
Buy Volume
€1m
2 ops.
Sell Volume
32Σ signal
Fundamental score
Ranked 14,776 of 29,064 companies
51.6
score / 100
Value32
Quality71
FCF yld1.3%
Earn yld1.6%
EV/EBITDA36.6x
ROE7.5%
Gross mgn90%
Net mgn18%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 May 2026
Declarations8 total
4,146 shares@ €1.670.0057% mcap50.0% of flowAktieISIN SE0002485979FI:csv-3038ed09a69538b751f4
4,146 shares@ SEK 18.4490.0057% mcap100.0% of flowAktieISIN SE0002485979FI:A003Y639-1
2,470 shares@ €1.58930.0033% mcap100.0% of flowAktieISIN SE0002485979FI:A003W421-1
13,000 shares@ €1.63640.018% mcap48.8% of flowAktieISIN SE0002485979FI:A003W055-1
38,340 shares@ €2.4640.078% mcap100.0% of flowAktieISIN SE0002485979FI:A003O980-1
255,653 shares@ €2.34420.50% mcap52.5% of flowAktieISIN SE0002485979FI:A003O854-1
235,000 shares@ €2.30380.45% mcap47.5% of flowAktieISIN SE0002485979FI:A003M263-1
10,418 shares@ €2.14360.019% mcap51.2% of flowAktieISIN SE0002485979FI:A003M248-1
8 of 8 declarations
关于 Genovis AB
Genovis AB 是一家专注于生物制药技术开发的公司，特别是抗体修饰工具。该公司在 XSTO 交易所上市。
